• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova .

作者信息

Zeidler Henning

出版信息

Ann Rheum Dis. 2017 Jul;76(7):e16. doi: 10.1136/annrheumdis-2016-210887. Epub 2016 Dec 22.

DOI:10.1136/annrheumdis-2016-210887
PMID:28007758
Abstract
摘要

相似文献

1
Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova .类风湿关节炎中无药物持续缓解或自然病程的自发缓解？一个未解决的问题：对阿杰加诺娃文章的评论
Ann Rheum Dis. 2017 Jul;76(7):e16. doi: 10.1136/annrheumdis-2016-210887. Epub 2016 Dec 22.
2
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.在类风湿关节炎诊断时存在磁共振成像检测到的骨炎是否会降低达到疾病修饰抗风湿药物无持续缓解的风险：一项纵向研究的结果。
Arthritis Res Ther. 2018 Apr 10;20(1):68. doi: 10.1186/s13075-018-1553-8.
3
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素：来自两个大型早期关节炎队列的结果
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.
4
Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.抗环瓜氨酸肽抗体阴性的类风湿关节炎是否由与持续无改善病情抗风湿药缓解及疾病初发时的血清学标志物相关的亚组构成？对Boeters DM等人文章的评论
Arthritis Res Ther. 2020 Jan 31;22(1):17. doi: 10.1186/s13075-020-2106-5.
5
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.类风湿关节炎的疾病缓解药物停药后持续缓解：随着疾病症状的消退，越来越有可能实现这一目标。
Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13.
6
Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka ' by Berkhout .对Berkhout对Tanaka的《类风湿关节炎患者缓解后采用递增剂量策略持续停用英夫利昔单抗：RRRR研究，一项随机对照试验》的评论的回应
Ann Rheum Dis. 2021 Nov;80(11):e173. doi: 10.1136/annrheumdis-2019-216593. Epub 2019 Dec 9.
7
Definition of rheumatoid arthritis remission in clinical practice: comment on the article by Felson et al.临床实践中类风湿关节炎缓解的定义：对费尔森等人文章的评论
Arthritis Rheum. 2011 Nov;63(11):3642; author's reply 3644. doi: 10.1002/art.30554.
8
Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka .对田中发表的《类风湿关节炎患者缓解后采用递增剂量策略持续停用英夫利昔单抗：RRRR研究，一项随机对照试验》的评论
Ann Rheum Dis. 2021 Nov;80(11):e172. doi: 10.1136/annrheumdis-2019-216557. Epub 2019 Nov 19.
9
Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.达到早期类风湿关节炎或未分化关节炎患者缓解后一年无药物缓解的决定因素——缓解导向治疗。
Rheumatology (Oxford). 2015 Aug;54(8):1380-4. doi: 10.1093/rheumatology/keu477. Epub 2015 Feb 15.
10
Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et al.类风湿关节炎达标治疗研究中的缓解分类：对诺凡格等人文章的评论
Arthritis Rheumatol. 2020 Aug;72(8):1406-1407. doi: 10.1002/art.41269. Epub 2020 Jun 12.

引用本文的文献

1
Association between rs2476601, rs833070, rs6920220 Polymorphisms and Risk for Rheumatoid Arthritis in Early Undifferentiated Arthritis Patients: A Pilot Study.rs2476601、rs833070、rs6920220 多态性与早期未分化关节炎患者类风湿关节炎风险的关联：一项初步研究。
Medicina (Kaunas). 2023 Oct 13;59(10):1824. doi: 10.3390/medicina59101824.
2
ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation.ACPA 阴性和 ACPA 阳性 RA 患者达到疾病缓解时表现出不同的 MRI 检测到的关节炎症模式。
Rheumatology (Oxford). 2022 Dec 23;62(1):124-134. doi: 10.1093/rheumatology/keac294.
3
Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution.
解析 ACPA 阴性类风湿关节炎的异质性：在开始 DMARD 治疗时具有强烈临床和血清学反应的患者亚组有利于疾病缓解。
Arthritis Res Ther. 2022 Jan 3;24(1):4. doi: 10.1186/s13075-021-02671-z.
4
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis.开始使用改善病情抗风湿药（DMARD）后早期疾病活动评分（DAS）反应增加类风湿关节炎实现无DMARD持续缓解的概率。
Arthritis Res Ther. 2020 Nov 23;22(1):276. doi: 10.1186/s13075-020-02368-9.
5
DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability.无 DMARD 缓解作为类风湿关节炎的新型治疗目标：实现和可持续性的系统文献回顾。
RMD Open. 2020 May;6(1). doi: 10.1136/rmdopen-2020-001220.